Cathy Eason, MS, BCHN is Chief Science Officer at Berkeley Life, where she leads scientific strategy, product integrity, and evidence-based education across the company’s nitric oxide–focused portfolio. With advanced training in human nutrition and physiology, she specializes in translating complex biology—nitric oxide signaling, endothelial function, menopause physiology, and healthy aging—into clinically relevant insights for healthcare providers, performance professionals, and health and wellness leaders. Her work helps bridge science, regulation, and real-world application to advance long-term healthspan.